Autek China Inc. (SHE:300595)
China
· Delayed Price · Currency is CNY 15.41
+0.16 (1.05%)
Mar 10, 2026, 12:14 PM CST
Autek China Revenue
Autek China had revenue of 562.10M CNY in the quarter ending September 30, 2025, with 2.62% growth. This brings the company's revenue in the last twelve months to 1.82B, down -1.80% year-over-year. In the year 2024, Autek China had annual revenue of 1.81B with 4.40% growth.
Revenue (ttm)
1.82B
Revenue Growth
-1.80%
P/S Ratio
7.52
Revenue / Employee
507.10K
Employees
3,580
Market Cap
13.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.81B | 76.44M | 4.40% |
| Dec 31, 2023 | 1.74B | 211.85M | 13.89% |
| Jan 1, 2023 | 1.53B | 230.27M | 17.78% |
| Jan 1, 2022 | 1.30B | 424.38M | 48.74% |
| Dec 31, 2020 | 870.66M | 223.76M | 34.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Micro-Tech (Nanjing) Co.,Ltd | 3.19B |
| Jiangsu Hualan New Pharmaceutical Material | 604.86M |
| Tofflon Science and Technology Group | 5.22B |
| Eyebright Medical Technology (Beijing) | 1.48B |
| Shenyang Xingqi Pharmaceutical | 2.41B |
| Tinavi Medical Technologies | 283.26M |
| Sansure Biotech | 1.65B |
| Winner Medical | 10.80B |